enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Could a cancer drug help treat early Alzheimer’s? Study ...

   www.aol.com/could-cancer-drug-help-treat...

   Treatment with the cancer drug restored function in the hippocampus in an Alzheimer’s mouse model. It has long been understood that glucose metabolism in the brain is disrupted by aging and ...

3. Hormone therapy for breast cancer may help lower Alzheimer’s ...

   www.aol.com/hormone-therapy-breast-cancer-may...

   Hormone-modulating therapy for breast cancer is associated with a 7% lower risk of developing Alzheimer's disease and related dementias later in life, a new study indicates.

4. Decades-old human growth hormone treatments linked to five ...

   www.aol.com/news/human-growth-hormone-cadavers...

   Human growth hormone derived from cadavers was linked to Alzheimer's disease in five patients who received injections decades ago, a study in Nature Medicine finds. ... for several years as a ...

5. Glycerophosphorylcholine - Wikipedia

   en.wikipedia.org/wiki/Glycerophosphorylcholine

   L-α-Glycerophosphorylcholine (alpha-GPC, choline alfoscerate, sn-glycero-3-phosphocholine) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor [ 1 ] which has been investigated for its potential for the treatment of Alzheimer's disease [ 2 ] and other dementias .

6. Anti-amyloid drugs - Wikipedia

   en.wikipedia.org/wiki/Anti-amyloid_drugs

   Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...

7. Simufilam - Wikipedia

   en.wikipedia.org/wiki/Simufilam

   The publishing journals have issued expressions of concern for studies related to the pharmacology. [17] [20] [21]Burns and Wang reported in 2008 that FLNA contains the high-affinity binding site of naloxone and naltrexone in preventing opioid tolerance and dependence, [17] and in 2020 that by disrupting that simufilam reduces the ultra-tight binding of amyloid beta 42 to the alpha-7 nicotinic ...